Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-061223
Filing Date
2013-11-14
Accepted
2013-11-14 06:20:52
Documents
10
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v360030_10q.htm 10-Q 1121973
2 EXHIBIT 31.1 v360030_ex31-1.htm EX-31.1 11233
3 EXHIBIT 31.2 v360030_ex31-2.htm EX-31.2 11223
4 EXHIBIT 32.1 v360030_ex32-1.htm EX-32.1 12410
  Complete submission text file 0001144204-13-061223.txt   6813429

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT icpt-20130930.xml EX-101.INS 1052548
6 XBRL TAXONOMY EXTENSION SCHEMA icpt-20130930.xsd EX-101.SCH 63216
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE icpt-20130930_cal.xml EX-101.CAL 29010
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE icpt-20130930_def.xml EX-101.DEF 246336
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE icpt-20130930_lab.xml EX-101.LAB 355478
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE icpt-20130930_pre.xml EX-101.PRE 296563
Mailing Address 18 Desbrosses Street New York NY 10013
Business Address 18 Desbrosses Street NEW YORK NY 10013 646-747-1000
INTERCEPT PHARMACEUTICALS INC (Filer) CIK: 0001270073 (see all company filings)

EIN.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35668 | Film No.: 131216684
SIC: 2834 Pharmaceutical Preparations